Beta Glucan for the Treatment of Human Papilloma Virus (HPV) and Cervical Cancer
- By Betül Gürünlü1
-
View Affiliations Hide Affiliations1 "Üsküdar Üniversitesi, Biyomühendislik Bölümü, Merkez Yerleşke A Blok 325/AAltunizade, Üsküdar, İstanbul, Turkey"
- Source: Medical Applications of Beta-Glucan , pp 130-142
- Publication Date: January 2022
- Language: English
Beta Glucan for the Treatment of Human Papilloma Virus (HPV) and Cervical Cancer, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/9789815039238/chapter-14-1.gif
<div>Cervical cancer is the fourth most frequently diagnosed cancer. For the</div><div>treatment of this relentless disease, chemotherapy is the most widely applied cure now.</div><div>However, this treatment carries some important side effects, such as neutropenia which</div><div>having an abnormally low concentration of neutrophils in the blood. Also,</div><div>chemotherapeutic drugs cause harm to blood formation. Therefore, chemotherapy</div><div>affects the patients' immune system badly by making them open to infections. Another</div><div>treatment method is radiotherapy for the healing of cervical cancer. This technique also</div><div>carries some side effects being hematopoietic and harm to the immune system. Betaglucans</div><div>modulates the immune system by affecting a wide range of cells like antigenpresenting</div><div>cells (APCs), including macrophages, dendritic cells, T cells, monocytes. It</div><div>regulates both adaptive and innate immune systems. It has different kinds such as</div><div>sizofiran (SPG), zymosan, curdlan, and PBG to prevent and protect from cervical</div><div>cancer. Beta-glucan provides a novel therapeutic method for the healing of human</div><div>papillomavirus (HPV) and cervical cancer.</div>
-
From This Site
/content/books/9789815039238.chapter-14dcterms_subject,pub_keyword-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData105